受强制性开放获取政策约束的文章 - Petra M Nederlof了解详情
可在其他位置公开访问的文章：27 篇
AACR Project GENIE: powering precision medicine through an international consortium
AACR Project Genie Consortium, AACR Project GENIE Consortium, ...
Cancer discovery 7 (8), 818-831, 2017
强制性开放获取政策： US National Institutes of Health, Howard Hughes Medical Institute, Dutch …
BRCA1 tumour suppression occurs via heterochromatin-mediated silencing
Q Zhu, GM Pao, AM Huynh, H Suh, N Tonnu, PM Nederlof, FH Gage, ...
Nature 477 (7363), 179-184, 2011
强制性开放获取政策： US National Institutes of Health
The Drug Rediscovery protocol facilitates the expanded use of existing anticancer drugs
DL van der Velden, LR Hoes, H Van Der Wijngaart, ...
Nature 574 (7776), 127-131, 2019
强制性开放获取政策： Dutch Cancer Society
High incidence of protein-truncating TP53 mutations in BRCA1-related breast cancer
H Holstege, SA Joosse, CTM van Oostrom, PM Nederlof, A de Vries, ...
Cancer research 69 (8), 3625-3633, 2009
强制性开放获取政策： US National Institutes of Health
Identification of recurrent FGFR3 fusion genes in lung cancer through kinome‐centred RNA sequencing
IJ Majewski, L Mittempergher, NM Davidson, A Bosma, SM Willems, ...
The Journal of pathology 230 (3), 270-276, 2013
强制性开放获取政策： National Health and Medical Research Council, Australia
Genomic patterns resembling BRCA1- and BRCA2-mutated breast cancers predict benefit of intensified carboplatin-based chemotherapy
MA Vollebergh, EH Lips, PM Nederlof, LFA Wessels, J Wesseling, ...
Breast Cancer Research 16, 1-13, 2014
强制性开放获取政策： Dutch Cancer Society
Functional Ex Vivo Assay Reveals Homologous Recombination Deficiency in Breast Cancer Beyond BRCA Gene Defects
TG Meijer, NS Verkaik, AM Sieuwerts, J van Riet, KAT Naipal, ...
Clinical cancer research 24 (24), 6277-6287, 2018
强制性开放获取政策： Netherlands Organisation for Scientific Research, Dutch Cancer Society
Pathogenicity of the BRCA1 missense variant M1775K is determined by the disruption of the BRCT phosphopeptide-binding pocket: a multi-modal approach
M Tischkowitz, N Hamel, MA Carvalho, G Birrane, A Soni, EH Van Beers, ...
European journal of human genetics 16 (7), 820-832, 2008
强制性开放获取政策： US National Institutes of Health
Immune-escape markers in relation to clinical outcome of advanced melanoma patients following immunotherapy
EPM Tjin, G Krebbers, KJ Meijlink, W van de Kasteele, EH Rosenberg, ...
Cancer immunology research 2 (6), 538-546, 2014
强制性开放获取政策： Dutch Cancer Society
Robust BRCA1-like classification of copy number profiles of samples repeated across different datasets and platforms
PC Schouten, A Grigoriadis, T Kuilman, H Mirza, JA Watkins, SA Cooke, ...
Molecular oncology 9 (7), 1274-1286, 2015
强制性开放获取政策： Cancer Research UK, UK Medical Research Council
Comprehensive routine diagnostic screening to identify predictive mutations, gene amplifications, and microsatellite instability in FFPE tumor material
EMP Steeghs, LI Kroeze, BBJ Tops, LC van Kempen, A Ter Elst, ...
BMC cancer 20, 1-15, 2020
强制性开放获取政策： Netherlands Organisation for Health Research and Development
Recommendations for the clinical interpretation and reporting of copy number gains using gene panel NGS analysis in routine diagnostics
A Eijkelenboom, BBJ Tops, A van den Berg, AJC van den Brule, ...
Virchows Archiv 474, 673-680, 2019
强制性开放获取政策： Netherlands Organisation for Health Research and Development
Exome sequencing of germline DNA from non-BRCA1/2 familial breast cancer cases selected on the basis of aCGH tumor profiling
FS Hilbers, CM Meijers, JFJ Laros, M van Galen, N Hoogerbrugge, ...
PloS one 8 (1), e55734, 2013
强制性开放获取政策： Dutch Cancer Society
Effect of HIPEC according to HRD/BRCAwt genomic profile in stage III ovarian cancer: Results from the phase III OVHIPEC trial
SN Koole, PC Schouten, J Hauke, RJC Kluin, P Nederlof, LK Richters, ...
International Journal of Cancer 151 (8), 1394-1404, 2022
强制性开放获取政策： US National Institutes of Health, Dutch Cancer Society
Estrogen receptor α wields treatment-specific enhancers between morphologically similar endometrial tumors
M Droog, E Nevedomskaya, GM Dackus, R Fles, Y Kim, H Hollema, ...
Proceedings of the National Academy of Sciences 114 (8), E1316-E1325, 2017
强制性开放获取政策： Dutch Cancer Society
Identification of BRCA1-like triple-negative breast cancers by quantitative multiplex-ligation-dependent probe amplification (MLPA) analysis of BRCA1-associated chromosomal …
E Gross, H van Tinteren, Z Li, S Raab, C Meul, S Avril, N Laddach, ...
BMC cancer 16, 1-10, 2016
强制性开放获取政策： US National Institutes of Health
POSEIDON trial phase 1B results: Safety, efficacy and circulating tumor DNA response of the beta isoform-sparing PI3K inhibitor taselisib (GDC-0032) combined with tamoxifen in …
RD Baird, AGJ van Rossum, M Oliveira, K Beelen, M Gao, M Schrier, ...
Clinical Cancer Research 25 (22), 6598-6605, 2019
强制性开放获取政策： Cancer Research UK, National Institute for Health Research, UK
Comprehensive characterization of pre-and post-treatment samples of breast cancer reveal potential mechanisms of chemotherapy resistance
M Hoogstraat, EH Lips, I Mayayo-Peralta, L Mulder, P Kristel, ...
NPJ Breast Cancer 8 (1), 60, 2022
强制性开放获取政策： Dutch Cancer Society
Adjuvant capecitabine-containing chemotherapy benefit and homologous recombination deficiency in early-stage triple-negative breast cancer patients
LW de Boo, K Jóźwiak, H Joensuu, H Lindman, S Lauttia, M Opdam, ...
British Journal of Cancer 126 (10), 1401-1409, 2022
强制性开放获取政策： Dutch Cancer Society
BRCAness digitalMLPA profiling predicts benefit of intensified platinum-based chemotherapy in triple-negative and luminal-type breast cancer
EH Lips, A Benard-Slagter, M Opdam, CE Scheerman, J Wesseling, ...
Breast Cancer Research 22, 1-12, 2020
强制性开放获取政策： Cancer Research UK, Dutch Cancer Society
出版信息和资助信息由计算机程序自动确定